Enhancing Industrial Cultivation: A Breakthrough Approach Using Methylated Compounds to Expedite Microbial Growth
This project aims to reduce microbial cultivation costs by shortening the lag phase using methylated compounds, potentially revolutionizing the industry and enhancing product yield.
Projectdetails
Introduction
Industries reliant on microbial cultivation face high production costs, with the cultivation process accounting for 20-40% of the total. However, conventional strategies often overlook the lag phase, an early growth phase in which bacteria do not grow, that significantly elongates the cultivation process and impacts production costs.
Recent Findings
Recent findings arising from our ERC-funded research reveal a ground-breaking mechanism for modulating bacterial lag phase duration. Through the addition of naturally abundant methylated compounds during the lag phase, we demonstrate a strategy to expedite bacterial growth by up to 10 hours. This approach, previously unexplored due to technical challenges, could revolutionize industrial cultivation, reducing costs and enhancing product yield.
Novel Regulatory Circuit
Our ERC-funded research uncovered a novel regulatory circuit influencing the bacterial lag phase. In our research of algal-bacterial routes of metabolic exchange, we discovered that abundant methylated compounds produced by algae and plants can significantly expedite the lag phase of various bacteria.
Mechanism Insights
Detailed insights into this mechanism enabled tailored treatments that shorten lag phases by utilizing methylated compounds. This approach presents a safe, affordable, and unique solution for industry challenges.
Proposal Overview
In this proposal, we outline a comprehensive plan to address current industrial cultivation challenges and exploit our innovative approach. By leveraging methylated compounds to expedite lag phases, both in bacteria and yeast, we aim to:
- Optimize yield
- Revolutionize microbial cultivation
- Potentially transform an industry with an expected value of $130-180 billion by 2030
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-7-2024 |
Einddatum | 31-12-2025 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- WEIZMANN INSTITUTE OF SCIENCEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Translating a new metabolic engineering strategy to industrial biotech applicationsThe TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production. | ERC Proof of... | € 150.000 | 2023 | Details |
Scalable Microbial Metabolite Discovery Through Synthetic BiologyThis project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development. | ERC Starting... | € 1.490.250 | 2024 | Details |
Microbial Synthetic in vivo Cell Therapy SystemsThe MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways. | ERC Starting... | € 1.499.938 | 2023 | Details |
Flux Race Investigation for Dissection Of Metabolic-bottlenecks: Leveraging the tremendous potential of algal metabolic diversityThis project aims to identify metabolic bottlenecks in photosynthetic cells using advanced flux analyses to enhance crop yields and meet future food production demands sustainably. | ERC Starting... | € 1.937.500 | 2023 | Details |
Production of a second phase of hydrophobic aromatics with solvent-tolerant PseudomonasThe PROSPER project aims to engineer solvent-tolerant Pseudomonas for efficient microbial production of hydrophobic aromatic chemicals, overcoming toxicity barriers for sustainable biotechnological applications. | ERC Consolid... | € 1.999.485 | 2023 | Details |
Translating a new metabolic engineering strategy to industrial biotech applications
The TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production.
Scalable Microbial Metabolite Discovery Through Synthetic Biology
This project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development.
Microbial Synthetic in vivo Cell Therapy Systems
The MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways.
Flux Race Investigation for Dissection Of Metabolic-bottlenecks: Leveraging the tremendous potential of algal metabolic diversity
This project aims to identify metabolic bottlenecks in photosynthetic cells using advanced flux analyses to enhance crop yields and meet future food production demands sustainably.
Production of a second phase of hydrophobic aromatics with solvent-tolerant Pseudomonas
The PROSPER project aims to engineer solvent-tolerant Pseudomonas for efficient microbial production of hydrophobic aromatic chemicals, overcoming toxicity barriers for sustainable biotechnological applications.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Biosensor Activated Biomanufacturing Scale-upEnduro aims to revolutionize microbial biomanufacturing with its synthetic biology plugin, Enduro Sense, to enable scalable processes and attract investment for commercial deployment. | EIC Accelerator | € 1.815.295 | 2023 | Details |
TUNGSTEN BIOCATALYSIS – HEAVY METAL ENZYMES FOR SUSTAINABLE INDUSTRIAL BIOCATALYSISThis project aims to develop a new W-cofactor biosynthesis pathway in E. coli to produce tungsten-containing enzymes for sustainable chemical processes, enabling efficient CO2 reduction and cosmetic ingredient production. | EIC Pathfinder | € 2.430.574 | 2024 | Details |
Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infectionsLeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations. | EIC Pathfinder | € 2.665.564 | 2022 | Details |
Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analoguesThe MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026. | EIC Accelerator | € 2.441.250 | 2024 | Details |
Biosensor Activated Biomanufacturing Scale-up
Enduro aims to revolutionize microbial biomanufacturing with its synthetic biology plugin, Enduro Sense, to enable scalable processes and attract investment for commercial deployment.
TUNGSTEN BIOCATALYSIS – HEAVY METAL ENZYMES FOR SUSTAINABLE INDUSTRIAL BIOCATALYSIS
This project aims to develop a new W-cofactor biosynthesis pathway in E. coli to produce tungsten-containing enzymes for sustainable chemical processes, enabling efficient CO2 reduction and cosmetic ingredient production.
Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections
LeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations.
Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analogues
The MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026.